In natalizumab-treated patients without previous immunosuppressive treatment, the JCV antibody index is used to stratify PML risk. A high index value indicates that the risk to develop PML is significantly elevated, although probably about 99% of patients with this index value will not develop PML. This minireview aimed to provide an overview of the basic virology and immunology relevant to understanding JCV infections in MS patients, with a focus on what is presently known about antibodies to JCV and how they could be of use to predict and diagnose PML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ane.12840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Induced biochemical variations in maize parental lines affect the life table and age-specific reproductive potential of (J.E. Smith).
Front Plant Sci
December 2024
Division of Entomology, ICAR-Indian Agricultural Research Institute, New Delhi, India.
In recent years, the fall armyworm, has rapidly emerged as a global invasive pest, challenging the maize production and leading to considerable economic losses. Developing resistant hybrids is essential for sustainable maize cultivation, which requires a comprehensive understanding of resistance traits and the underlying mechanisms in parental lines. To address this need, the present study aimed to identify the sources of resistance, age and stage-specific effects and role of phytochemicals in plant defense against in thirty diverse maize parental lines [17 female (A) and 13 male (R) lines].
View Article and Find Full Text PDFParallel Proteomic and Transcriptomic Microenvironment Mapping (μMap) of Nuclear Condensates in Living Cells.
J Am Chem Soc
December 2024
Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States.
Cellular activity is spatially organized across different organelles. While several structures are well-characterized, many organelles have unknown roles. Profiling biomolecular composition is key to understanding function but is difficult to achieve in the context of small, dynamic structures.
View Article and Find Full Text PDFEpigenetic Therapies.
Cold Spring Harb Perspect Med
December 2024
Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts 02215, USA
Epigenetic therapies are emerging for pediatric cancers. Due to the relatively low mutational burden in pediatric tumors, epigenetic dysregulation and differentiation blockade is a hallmark of oncogenesis in some childhood cancers. By targeting epigenetic regulators that maintain tumor cells in a primitive developmental state, epigenetic therapies may induce differentiation.
View Article and Find Full Text PDFAcute lower limb ischemia revealing hypo granular acute promyelocytic leukemia.
Leuk Res Rep
November 2024
Hematology Laboratory, Central laboratory, Mohammed VI University Hospital, Oujda, Morocco.
Introduction: Acute promyelocytic leukemia (AML-M3), classified as acute Myeloid leukemia with PML RARA according to the 5th edition of the World Health Organization classification of haematolymphoid tumors 2022 [1], is marked by abnormal promyelocyte proliferation and is known for high risks of bleeding and thromboembolic complications. We present a case where lower limb ischemia revealed this leukemia in a child.
Case Report: An 11-year-old with minor ankle trauma developed severe lower limb ischemia, leading to the discovery of subtotal femoral artery thrombosis.
Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats.
Mol Ther
December 2024
Gladstone Institute of Neurological Disease, San Francisco, CA, USA; University of California, San Francisco, Department of Neurology, and the Kavli Institute for Fundamental Neuroscience, San Francisco, CA, USA; University of California, San Francisco, Neurosciences Graduate Program, San Francisco, CA, USA. Electronic address:
Allogeneic modified bone marrow-derived human mesenchymal stromal/stem cells (hMSC-SB623 cells) are in clinical development for the treatment of chronic motor deficits after traumatic brain injury and cerebral ischemic stroke. However, their exact mechanisms of action remain unclear. Here, we investigated the effects of this cell therapy on cortical network excitability, brain tissue, and peripheral blood at a chronic stage after ischemic stroke in a rat model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!